Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 82

1.

Expression of protein tyrosine kinase 6 (PTK6) in nonsmall cell lung cancer and their clinical and prognostic significance.

Zhao C, Chen Y, Zhang W, Zhang J, Xu Y, Li W, Chen S, Deng A.

Onco Targets Ther. 2013;6:183-8. doi: 10.2147/OTT.S41283. Epub 2013 Mar 8.

PMID:
23525678
[PubMed]
Free PMC Article
2.

Low expression of PTK6/Brk predicts poor prognosis in patients with laryngeal squamous cell carcinoma.

Liu XK, Zhang XR, Zhong Q, Li MZ, Liu ZM, Lin ZR, Wu D, Zeng MS.

J Transl Med. 2013 Mar 7;11:59. doi: 10.1186/1479-5876-11-59.

PMID:
23497344
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Overexpression of periostin predicts poor prognosis in non-small cell lung cancer.

Hong LZ, Wei XW, Chen JF, Shi Y.

Oncol Lett. 2013 Dec;6(6):1595-1603. Epub 2013 Sep 18.

PMID:
24273600
[PubMed]
Free PMC Article
4.

Prognostic significance of p53 and ras p21 expression in nonsmall cell lung cancer.

Fujino M, Dosaka-Akita H, Harada M, Hiroumi H, Kinoshita I, Akie K, Kawakami Y.

Cancer. 1995 Dec 15;76(12):2457-63.

PMID:
8625071
[PubMed - indexed for MEDLINE]
5.
6.

Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival.

Liao WT, Wang X, Xu LH, Kong QL, Yu CP, Li MZ, Shi L, Zeng MS, Song LB.

Cancer. 2009 Apr 1;115(7):1507-17. doi: 10.1002/cncr.24128.

PMID:
19170237
[PubMed - indexed for MEDLINE]
Free Article
7.

Expression of the recepteur d'originenantais receptor tyrosine kinase in non-small cell lung cancer and its clinical significance.

Han WL, Li WD, Hu J, Rusidanmu A, Chen LF, Shen L, Zheng SS.

Chin Med J (Engl). 2012 Mar;125(6):1110-4.

PMID:
22613539
[PubMed - indexed for MEDLINE]
8.

Altered retinoblastoma protein expression in nonsmall cell lung cancer: its synergistic effects with altered ras and p53 protein status on prognosis.

Dosaka-Akita H, Hu SX, Fujino M, Harada M, Kinoshita I, Xu HJ, Kuzumaki N, Kawakami Y, Benedict WF.

Cancer. 1997 Apr 1;79(7):1329-37.

PMID:
9083154
[PubMed - indexed for MEDLINE]
9.

Prognostic value of protein tyrosine kinase 6 (PTK6) for long-term survival of breast cancer patients.

Aubele M, Walch AK, Ludyga N, Braselmann H, Atkinson MJ, Luber B, Auer G, Tapio S, Cooke T, Bartlett JM.

Br J Cancer. 2008 Oct 7;99(7):1089-95. doi: 10.1038/sj.bjc.6604660. Epub 2008 Sep 9.

PMID:
18781181
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Downregulated expression of PTK6 is correlated with poor survival in esophageal squamous cell carcinoma.

Chen YF, Ma G, Cao X, Huang ZL, Zeng MS, Wen ZS.

Med Oncol. 2014 Dec;31(12):317. doi: 10.1007/s12032-014-0317-9. Epub 2014 Nov 7.

PMID:
25377660
[PubMed - in process]
11.

Overexpression of PTK6 (breast tumor kinase) protein--a prognostic factor for long-term breast cancer survival--is not due to gene amplification.

Aubele M, Vidojkovic S, Braselmann H, Ritterswürden D, Auer G, Atkinson MJ, Tapio S, Höfler H, Rauser S, Bartlett JM.

Virchows Arch. 2009 Aug;455(2):117-23. doi: 10.1007/s00428-009-0809-8. Epub 2009 Jul 21.

PMID:
19621240
[PubMed - indexed for MEDLINE]
12.

Total cyclooxygenase-2 mRNA levels correlate with vascular endothelial growth factor mRNA levels, tumor angiogenesis and prognosis in non-small cell lung cancer patients.

Yuan A, Yu CJ, Shun CT, Luh KT, Kuo SH, Lee YC, Yang PC.

Int J Cancer. 2005 Jul 1;115(4):545-55.

PMID:
15704107
[PubMed - indexed for MEDLINE]
13.

Overexpression of Jun activation domain-binding protein 1 in nonsmall cell lung cancer and its significance in p27 expression and clinical features.

Osoegawa A, Yoshino I, Kometani T, Yamaguchi M, Kameyama T, Yohena T, Maehara Y.

Cancer. 2006 Jul 1;107(1):154-61.

PMID:
16721818
[PubMed - indexed for MEDLINE]
Free Article
14.

Clinical significance of SH2B1 adaptor protein expression in non-small cell lung cancer.

Zhang H, Duan CJ, Chen W, Wang SQ, Zhang SK, Dong S, Cheng YD, Zhang CF.

Asian Pac J Cancer Prev. 2012;13(5):2355-62.

PMID:
22901222
[PubMed - indexed for MEDLINE]
Free Article
15.

Prognostic significance of serum miRNA-21 expression in human non-small cell lung cancer.

Wang ZX, Bian HB, Wang JR, Cheng ZX, Wang KM, De W.

J Surg Oncol. 2011 Dec;104(7):847-51. doi: 10.1002/jso.22008. Epub 2011 Jun 30.

PMID:
21721011
[PubMed - indexed for MEDLINE]
16.

Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer.

Wu YH, Cheng YW, Chang JT, Wu TC, Chen CY, Lee H.

Cancer. 2007 Jul 1;110(1):215-23.

PMID:
17508409
[PubMed - indexed for MEDLINE]
Free Article
17.

Prognostic significance of STAT3 expression and its correlation with chemoresistance of non-small cell lung cancer cells.

Yin Z, Zhang Y, Li Y, Lv T, Liu J, Wang X.

Acta Histochem. 2012 Feb;114(2):151-8. doi: 10.1016/j.acthis.2011.04.002. Epub 2011 May 6.

PMID:
21549414
[PubMed - indexed for MEDLINE]
18.

Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.

Zhao ZH, Wang SF, Yu L, Wang J, Chang H, Yan WL, Zhang J, Fu K.

Lung Cancer. 2008 Oct;62(1):113-9. doi: 10.1016/j.lungcan.2008.02.014. Epub 2008 Jun 11.

PMID:
18550205
[PubMed - indexed for MEDLINE]
19.

Mitogen-activated protein kinase phosphatase-1 is overexpressed in non-small cell lung cancer and is an independent predictor of outcome in patients.

Vicent S, Garayoa M, López-Picazo JM, Lozano MD, Toledo G, Thunnissen FB, Manzano RG, Montuenga LM.

Clin Cancer Res. 2004 Jun 1;10(11):3639-49.

PMID:
15173070
[PubMed - indexed for MEDLINE]
Free Article
20.

[MRP expression in non-small cell lung cancer and normal lung tissues and its prognostic significance].

Hao J, Wang Y, Li Q, Wang E, Qiu X, Liu Y.

Zhongguo Fei Ai Za Zhi. 2005 Feb 20;8(1):32-6. doi: 10.3779/j.issn.1009-3419.2005.01.07. Chinese.

PMID:
21187021
[PubMed]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk